Allmed Medical Products

Allmed Medical Products Co., Ltd. (奥美医疗用品股份有限公司), commonly shortened to Allmed Medical (奥美医疗), is a Chinese manufacturer of medical dressings and disposable medical consumables. The company is headquartered in Zhicheng, Yidu, in Hubei Province, and is listed on the Shenzhen Stock Exchange under the ticker 002950.SZ. Its core business is the research, development, production and sale of wound-care dressings — gauze, bandages, adhesive plasters, surgical drapes and related sterile products — together with disposable medical consumables such as masks, protective clothing, cotton swabs and surgical kits. Allmed built its position as an export-oriented contract manufacturer, supplying private-label and OEM wound-care products to hospitals, distributors and retail pharmacy chains in developed markets including the United States, Europe and Japan, before developing its own branded lines for the Chinese market. Its manufacturing base in Hubei gives it vertically integrated capacity spanning cotton processing, weaving, bleaching, sterilization and packaging, which is central to its cost position in a category where scale and quality certification matter more than brand marketing. The company became far more visible to Chinese consumers during the COVID-19 pandemic, when demand for masks, protective clothing and other infection-control supplies surged and Allmed was among the domestic manufacturers scaling up output. That episode shifted its profile from a largely business-to-business exporter toward a supplier with a recognizable name in the domestic market, and it has since invested in higher-value wound-care and advanced dressing categories. Allmed competes in a fragmented global dressing industry alongside large international wound-care groups and numerous Chinese exporters. Its positioning rests on manufacturing scale, international quality certifications and OEM relationships rather than on consumer advertising, although its listed status and pandemic-era visibility have given the Allmed name broader recognition in China.

Allmed Medical Products was established in the late 1990s in Zhicheng, Yidu, Hubei Province, a region with a long cotton-textile tradition that made it a natural base for gauze and bandage production. From its early years the company oriented itself toward export markets, where demand for disposable wound-care dressings was large and where Chinese manufacturers could compete on cost once they met international quality and sterilization standards. Over the following two decades Allmed built out an integrated production chain — cotton processing, weaving, bleaching and dyeing, cutting, sterilization and sterile packaging — and accumulated the certifications required to supply hospitals and distributors in the United States, Europe and Japan. Much of this business was OEM and private-label: Allmed products reached end users under the brands of distributors and pharmacy chains rather than under its own name. This export-led model gave the company scale and manufacturing discipline but limited brand recognition. The company later moved to list on the Shenzhen Stock Exchange, trading under the code 002950.SZ, which gave it access to capital for capacity expansion and for developing higher-value product lines. Alongside its export business it built a domestic sales organization covering hospitals and retail pharmacies in China, promoting Allmed-branded dressings and consumables. The COVID-19 pandemic was a turning point in the company's public profile. With global and domestic demand for masks, protective clothing and infection-control supplies surging, Allmed expanded output of these items and became one of the Chinese manufacturers widely associated with pandemic supply. The surge in demand lifted revenue and brought the Allmed name to a much wider Chinese audience than its dressing business had reached. After the pandemic peak, the company faced the normalization of mask and protective-apparel demand and has focused on higher-value wound-care categories — advanced and specialty dressings — as well as on deepening domestic distribution. Its competitive position continues to rest on integrated manufacturing in Hubei, international certifications and long-standing OEM relationships with overseas customers.

• 2020

  Scaled up mask and protective-clothing output during the COVID-19 pandemic, sharply raising domestic brand visibility.

• 1997

  Company founded in Zhicheng, Yidu, Hubei, as a medical dressing manufacturer.

• Built integrated cotton-to-sterile-packaging production chain and obtained international quality certifications for export supply.

• Listed on the Shenzhen Stock Exchange under ticker 002950.SZ.

Scale-driven Chinese medical dressing and consumables manufacturer combining export OEM supply with a growing domestic brand presence.

• Medical gauze and bandages

• Adhesive plasters and wound dressings

• Surgical drapes and kits

• Face masks and protective clothing

• Cotton swabs and cotton products

• 2026-10-13

  Allmed Medical completes non-trade transfer of 1,694,281 repurchased shares to its 2026 employee stock ownership plan[1]奥美医疗2026年员工持股计划受让公司回购股份非交易过户完成cfi.net.cn

  On 13 October 2026, Allmed Medical Products Co., Ltd. (奥美医疗, stock code 002950) announced it had received a Securities Transfer Registration Confirmation from the Shenzhen Branch of China Securities Depository and Clearing Corporation: 1,694,281 repurchased A-shares, equal to 0.27% of total share capital, were transferred that day by non-trade transfer from the company's repurchase special securities account to the securities account of its 2026 employee stock ownership plan at a transfer price of 8.34 yuan per share (the plan had been expected to receive up to 2,642,685 shares). The plan was approved at the company's first extraordinary general meeting of 2026 on 30 June 2026 and actually raised 14,130,308.00 yuan, funded in equal parts (1:1) by a company special incentive fund and participant self-raised funds.

1. 1奥美医疗2026年员工持股计划受让公司回购股份非交易过户完成cfi.net.cn